▶ 調査レポート

世界のシタロプラム市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global Citalopram Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界のシタロプラム市場規模・現状・予測(2021年-2027年) / Global Citalopram Market Size, Status and Forecast 2021-2027 / QYR2104Z1346資料のイメージです。• レポートコード:QYR2104Z1346
• 出版社/出版日:QYResearch / 2021年4月15日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、128ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User/Five User¥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License(同一法人内共有可)¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査資料では、シタロプラムのグローバル市場(2016年~2027年)について調べ、市場動向、主要企業の市場シェア、種類別市場規模(溶剤、タブレット、その他)、用途別市場規模(うつ病、全般性不安障害、強迫性障害、身体表現性障害、統合失調症、その他)、主要地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、関連企業情報などを掲載しています。
・市場概要
・シタロプラムの市場動向
・企業の競争状況、市場シェア
・シタロプラムの種類別市場規模(溶剤、タブレット、その他)
・シタロプラムの用途別市場規模(うつ病、全般性不安障害、強迫性障害、身体表現性障害、統合失調症、その他)
・シタロプラムの北米市場規模2016-2027(アメリカ、カナダ)
・シタロプラムのヨーロッパ市場規模2016-2027(ドイツ、フランス、イギリス等)
・シタロプラムのアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・シタロプラムの中南米市場規模2016-2027(メキシコ、ブラジル)
・シタロプラムの中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(H.Lundbeck A/S、Amneal Pharmaceuticals、Aurobindo Pharma、Hetero Drugs、Macleods Pharmaceuticals、Silarx Pharmacueticals、Apotex、Hikma Pharmaceuticals、Jubilant Pharma、Lupin Limited、Prinston Pharmaceutical、STI Pharma、TEVA Pharmaceutical、Hexal、Shanghai Great Wall Pharmaceutical、Wanquan Wante Pharmaceutical、Northeast Pharmaceutical Group、Sichuan Kelun Pharmaceutical、Kunming Jida Pharmaceutical、Jiangsu Enhua Pharmaceutical、Southwest Pharmaceutical)
・結論

Citalopram is a selective serotonin reuptake inhibitor (SSRI), a racemate.It can selectively inhibit the 5-ht transporter, block the reuptake of 5-ht by the presynaptic membrane, prolong and increase the effect of 5-ht, and thus produce antidepressant effect.

Market Analysis and Insights: Global Citalopram Market
The global Citalopram market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Citalopram market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Citalopram market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Citalopram market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Citalopram market.

Global Citalopram Scope and Market Size
Citalopram market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Citalopram market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Solution
Tablets
Other

Segment by Application
Depression
Generalized Anxiety
Obsessive Compulsive Disorder
Somatoform Disorder
Schizophrenia
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
H.Lundbeck A/S
Amneal Pharmaceuticals
Aurobindo Pharma
Hetero Drugs
Macleods Pharmaceuticals
Silarx Pharmacueticals
Apotex
Hikma Pharmaceuticals
Jubilant Pharma
Lupin Limited
Prinston Pharmaceutical
STI Pharma
TEVA Pharmaceutical
Hexal
Shanghai Great Wall Pharmaceutical
Wanquan Wante Pharmaceutical
Northeast Pharmaceutical Group
Sichuan Kelun Pharmaceutical
Kunming Jida Pharmaceutical

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Citalopram Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Solution
1.2.3 Tablets
1.2.4 Other
1.3 Market by Application
1.3.1 Global Citalopram Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Depression
1.3.3 Generalized Anxiety
1.3.4 Obsessive Compulsive Disorder
1.3.5 Somatoform Disorder
1.3.6 Schizophrenia
1.3.7 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Citalopram Market Perspective (2016-2027)
2.2 Citalopram Growth Trends by Regions
2.2.1 Citalopram Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Citalopram Historic Market Share by Regions (2016-2021)
2.2.3 Citalopram Forecasted Market Size by Regions (2022-2027)
2.3 Citalopram Industry Dynamic
2.3.1 Citalopram Market Trends
2.3.2 Citalopram Market Drivers
2.3.3 Citalopram Market Challenges
2.3.4 Citalopram Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Citalopram Players by Revenue
3.1.1 Global Top Citalopram Players by Revenue (2016-2021)
3.1.2 Global Citalopram Revenue Market Share by Players (2016-2021)
3.2 Global Citalopram Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Citalopram Revenue
3.4 Global Citalopram Market Concentration Ratio
3.4.1 Global Citalopram Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Citalopram Revenue in 2020
3.5 Citalopram Key Players Head office and Area Served
3.6 Key Players Citalopram Product Solution and Service
3.7 Date of Enter into Citalopram Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Citalopram Breakdown Data by Type
4.1 Global Citalopram Historic Market Size by Type (2016-2021)
4.2 Global Citalopram Forecasted Market Size by Type (2022-2027)

5 Citalopram Breakdown Data by Application
5.1 Global Citalopram Historic Market Size by Application (2016-2021)
5.2 Global Citalopram Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Citalopram Market Size (2016-2027)
6.2 North America Citalopram Market Size by Type
6.2.1 North America Citalopram Market Size by Type (2016-2021)
6.2.2 North America Citalopram Market Size by Type (2022-2027)
6.2.3 North America Citalopram Market Size by Type (2016-2027)
6.3 North America Citalopram Market Size by Application
6.3.1 North America Citalopram Market Size by Application (2016-2021)
6.3.2 North America Citalopram Market Size by Application (2022-2027)
6.3.3 North America Citalopram Market Size by Application (2016-2027)
6.4 North America Citalopram Market Size by Country
6.4.1 North America Citalopram Market Size by Country (2016-2021)
6.4.2 North America Citalopram Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Citalopram Market Size (2016-2027)
7.2 Europe Citalopram Market Size by Type
7.2.1 Europe Citalopram Market Size by Type (2016-2021)
7.2.2 Europe Citalopram Market Size by Type (2022-2027)
7.2.3 Europe Citalopram Market Size by Type (2016-2027)
7.3 Europe Citalopram Market Size by Application
7.3.1 Europe Citalopram Market Size by Application (2016-2021)
7.3.2 Europe Citalopram Market Size by Application (2022-2027)
7.3.3 Europe Citalopram Market Size by Application (2016-2027)
7.4 Europe Citalopram Market Size by Country
7.4.1 Europe Citalopram Market Size by Country (2016-2021)
7.4.2 Europe Citalopram Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Citalopram Market Size (2016-2027)
8.2 Asia-Pacific Citalopram Market Size by Type
8.2.1 Asia-Pacific Citalopram Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Citalopram Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Citalopram Market Size by Type (2016-2027)
8.3 Asia-Pacific Citalopram Market Size by Application
8.3.1 Asia-Pacific Citalopram Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Citalopram Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Citalopram Market Size by Application (2016-2027)
8.4 Asia-Pacific Citalopram Market Size by Region
8.4.1 Asia-Pacific Citalopram Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Citalopram Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Citalopram Market Size (2016-2027)
9.2 Latin America Citalopram Market Size by Type
9.2.1 Latin America Citalopram Market Size by Type (2016-2021)
9.2.2 Latin America Citalopram Market Size by Type (2022-2027)
9.2.3 Latin America Citalopram Market Size by Type (2016-2027)
9.3 Latin America Citalopram Market Size by Application
9.3.1 Latin America Citalopram Market Size by Application (2016-2021)
9.3.2 Latin America Citalopram Market Size by Application (2022-2027)
9.3.3 Latin America Citalopram Market Size by Application (2016-2027)
9.4 Latin America Citalopram Market Size by Country
9.4.1 Latin America Citalopram Market Size by Country (2016-2021)
9.4.2 Latin America Citalopram Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Citalopram Market Size (2016-2027)
10.2 Middle East & Africa Citalopram Market Size by Type
10.2.1 Middle East & Africa Citalopram Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Citalopram Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Citalopram Market Size by Type (2016-2027)
10.3 Middle East & Africa Citalopram Market Size by Application
10.3.1 Middle East & Africa Citalopram Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Citalopram Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Citalopram Market Size by Application (2016-2027)
10.4 Middle East & Africa Citalopram Market Size by Country
10.4.1 Middle East & Africa Citalopram Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Citalopram Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 H.Lundbeck A/S
11.1.1 H.Lundbeck A/S Company Details
11.1.2 H.Lundbeck A/S Business Overview
11.1.3 H.Lundbeck A/S Citalopram Introduction
11.1.4 H.Lundbeck A/S Revenue in Citalopram Business (2016-2021)
11.1.5 H.Lundbeck A/S Recent Development
11.2 Amneal Pharmaceuticals
11.2.1 Amneal Pharmaceuticals Company Details
11.2.2 Amneal Pharmaceuticals Business Overview
11.2.3 Amneal Pharmaceuticals Citalopram Introduction
11.2.4 Amneal Pharmaceuticals Revenue in Citalopram Business (2016-2021)
11.2.5 Amneal Pharmaceuticals Recent Development
11.3 Aurobindo Pharma
11.3.1 Aurobindo Pharma Company Details
11.3.2 Aurobindo Pharma Business Overview
11.3.3 Aurobindo Pharma Citalopram Introduction
11.3.4 Aurobindo Pharma Revenue in Citalopram Business (2016-2021)
11.3.5 Aurobindo Pharma Recent Development
11.4 Hetero Drugs
11.4.1 Hetero Drugs Company Details
11.4.2 Hetero Drugs Business Overview
11.4.3 Hetero Drugs Citalopram Introduction
11.4.4 Hetero Drugs Revenue in Citalopram Business (2016-2021)
11.4.5 Hetero Drugs Recent Development
11.5 Macleods Pharmaceuticals
11.5.1 Macleods Pharmaceuticals Company Details
11.5.2 Macleods Pharmaceuticals Business Overview
11.5.3 Macleods Pharmaceuticals Citalopram Introduction
11.5.4 Macleods Pharmaceuticals Revenue in Citalopram Business (2016-2021)
11.5.5 Macleods Pharmaceuticals Recent Development
11.6 Silarx Pharmacueticals
11.6.1 Silarx Pharmacueticals Company Details
11.6.2 Silarx Pharmacueticals Business Overview
11.6.3 Silarx Pharmacueticals Citalopram Introduction
11.6.4 Silarx Pharmacueticals Revenue in Citalopram Business (2016-2021)
11.6.5 Silarx Pharmacueticals Recent Development
11.7 Apotex
11.7.1 Apotex Company Details
11.7.2 Apotex Business Overview
11.7.3 Apotex Citalopram Introduction
11.7.4 Apotex Revenue in Citalopram Business (2016-2021)
11.7.5 Apotex Recent Development
11.8 Hikma Pharmaceuticals
11.8.1 Hikma Pharmaceuticals Company Details
11.8.2 Hikma Pharmaceuticals Business Overview
11.8.3 Hikma Pharmaceuticals Citalopram Introduction
11.8.4 Hikma Pharmaceuticals Revenue in Citalopram Business (2016-2021)
11.8.5 Hikma Pharmaceuticals Recent Development
11.9 Jubilant Pharma
11.9.1 Jubilant Pharma Company Details
11.9.2 Jubilant Pharma Business Overview
11.9.3 Jubilant Pharma Citalopram Introduction
11.9.4 Jubilant Pharma Revenue in Citalopram Business (2016-2021)
11.9.5 Jubilant Pharma Recent Development
11.10 Lupin Limited
11.10.1 Lupin Limited Company Details
11.10.2 Lupin Limited Business Overview
11.10.3 Lupin Limited Citalopram Introduction
11.10.4 Lupin Limited Revenue in Citalopram Business (2016-2021)
11.10.5 Lupin Limited Recent Development
11.11 Prinston Pharmaceutical
11.11.1 Prinston Pharmaceutical Company Details
11.11.2 Prinston Pharmaceutical Business Overview
11.11.3 Prinston Pharmaceutical Citalopram Introduction
11.11.4 Prinston Pharmaceutical Revenue in Citalopram Business (2016-2021)
11.11.5 Prinston Pharmaceutical Recent Development
11.12 STI Pharma
11.12.1 STI Pharma Company Details
11.12.2 STI Pharma Business Overview
11.12.3 STI Pharma Citalopram Introduction
11.12.4 STI Pharma Revenue in Citalopram Business (2016-2021)
11.12.5 STI Pharma Recent Development
11.13 TEVA Pharmaceutical
11.13.1 TEVA Pharmaceutical Company Details
11.13.2 TEVA Pharmaceutical Business Overview
11.13.3 TEVA Pharmaceutical Citalopram Introduction
11.13.4 TEVA Pharmaceutical Revenue in Citalopram Business (2016-2021)
11.13.5 TEVA Pharmaceutical Recent Development
11.14 Hexal
11.14.1 Hexal Company Details
11.14.2 Hexal Business Overview
11.14.3 Hexal Citalopram Introduction
11.14.4 Hexal Revenue in Citalopram Business (2016-2021)
11.14.5 Hexal Recent Development
11.15 Shanghai Great Wall Pharmaceutical
11.15.1 Shanghai Great Wall Pharmaceutical Company Details
11.15.2 Shanghai Great Wall Pharmaceutical Business Overview
11.15.3 Shanghai Great Wall Pharmaceutical Citalopram Introduction
11.15.4 Shanghai Great Wall Pharmaceutical Revenue in Citalopram Business (2016-2021)
11.15.5 Shanghai Great Wall Pharmaceutical Recent Development
11.16 Wanquan Wante Pharmaceutical
11.16.1 Wanquan Wante Pharmaceutical Company Details
11.16.2 Wanquan Wante Pharmaceutical Business Overview
11.16.3 Wanquan Wante Pharmaceutical Citalopram Introduction
11.16.4 Wanquan Wante Pharmaceutical Revenue in Citalopram Business (2016-2021)
11.16.5 Wanquan Wante Pharmaceutical Recent Development
11.17 Northeast Pharmaceutical Group
11.17.1 Northeast Pharmaceutical Group Company Details
11.17.2 Northeast Pharmaceutical Group Business Overview
11.17.3 Northeast Pharmaceutical Group Citalopram Introduction
11.17.4 Northeast Pharmaceutical Group Revenue in Citalopram Business (2016-2021)
11.17.5 Northeast Pharmaceutical Group Recent Development
11.18 Sichuan Kelun Pharmaceutical
11.18.1 Sichuan Kelun Pharmaceutical Company Details
11.18.2 Sichuan Kelun Pharmaceutical Business Overview
11.18.3 Sichuan Kelun Pharmaceutical Citalopram Introduction
11.18.4 Sichuan Kelun Pharmaceutical Revenue in Citalopram Business (2016-2021)
11.18.5 Sichuan Kelun Pharmaceutical Recent Development
11.18 Kunming Jida Pharmaceutical
.1 Kunming Jida Pharmaceutical Company Details
.2 Kunming Jida Pharmaceutical Business Overview
.3 Kunming Jida Pharmaceutical Citalopram Introduction
.4 Kunming Jida Pharmaceutical Revenue in Citalopram Business (2016-2021)
.5 Kunming Jida Pharmaceutical Recent Development
11.20 Jiangsu Enhua Pharmaceutical
11.20.1 Jiangsu Enhua Pharmaceutical Company Details
11.20.2 Jiangsu Enhua Pharmaceutical Business Overview
11.20.3 Jiangsu Enhua Pharmaceutical Citalopram Introduction
11.20.4 Jiangsu Enhua Pharmaceutical Revenue in Citalopram Business (2016-2021)
11.20.5 Jiangsu Enhua Pharmaceutical Recent Development
11.21 Southwest Pharmaceutical
11.21.1 Southwest Pharmaceutical Company Details
11.21.2 Southwest Pharmaceutical Business Overview
11.21.3 Southwest Pharmaceutical Citalopram Introduction
11.21.4 Southwest Pharmaceutical Revenue in Citalopram Business (2016-2021)
11.21.5 Southwest Pharmaceutical Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Citalopram Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Solution
Table 3. Key Players of Tablets
Table 4. Key Players of Other
Table 5. Global Citalopram Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Citalopram Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Citalopram Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Citalopram Market Share by Regions (2016-2021)
Table 9. Global Citalopram Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Citalopram Market Share by Regions (2022-2027)
Table 11. Citalopram Market Trends
Table 12. Citalopram Market Drivers
Table 13. Citalopram Market Challenges
Table 14. Citalopram Market Restraints
Table 15. Global Citalopram Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Citalopram Market Share by Players (2016-2021)
Table 17. Global Top Citalopram Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Citalopram as of 2020)
Table 18. Ranking of Global Top Citalopram Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Citalopram Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Citalopram Product Solution and Service
Table 22. Date of Enter into Citalopram Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Citalopram Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Citalopram Revenue Market Share by Type (2016-2021)
Table 26. Global Citalopram Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Citalopram Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Citalopram Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Citalopram Revenue Market Share by Application (2016-2021)
Table 30. Global Citalopram Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Citalopram Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Citalopram Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Citalopram Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Citalopram Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Citalopram Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Citalopram Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Citalopram Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Citalopram Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Citalopram Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Citalopram Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Citalopram Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Citalopram Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Citalopram Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Citalopram Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Citalopram Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Citalopram Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Citalopram Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Citalopram Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Citalopram Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Citalopram Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Citalopram Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Citalopram Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Citalopram Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Citalopram Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Citalopram Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Citalopram Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Citalopram Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Citalopram Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Citalopram Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Citalopram Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Citalopram Market Size by Country (2022-2027) & (US$ Million)
Table 62. H.Lundbeck A/S Company Details
Table 63. H.Lundbeck A/S Business Overview
Table 64. H.Lundbeck A/S Citalopram Product
Table 65. H.Lundbeck A/S Revenue in Citalopram Business (2016-2021) & (US$ Million)
Table 66. H.Lundbeck A/S Recent Development
Table 67. Amneal Pharmaceuticals Company Details
Table 68. Amneal Pharmaceuticals Business Overview
Table 69. Amneal Pharmaceuticals Citalopram Product
Table 70. Amneal Pharmaceuticals Revenue in Citalopram Business (2016-2021) & (US$ Million)
Table 71. Amneal Pharmaceuticals Recent Development
Table 72. Aurobindo Pharma Company Details
Table 73. Aurobindo Pharma Business Overview
Table 74. Aurobindo Pharma Citalopram Product
Table 75. Aurobindo Pharma Revenue in Citalopram Business (2016-2021) & (US$ Million)
Table 76. Aurobindo Pharma Recent Development
Table 77. Hetero Drugs Company Details
Table 78. Hetero Drugs Business Overview
Table 79. Hetero Drugs Citalopram Product
Table 80. Hetero Drugs Revenue in Citalopram Business (2016-2021) & (US$ Million)
Table 81. Hetero Drugs Recent Development
Table 82. Macleods Pharmaceuticals Company Details
Table 83. Macleods Pharmaceuticals Business Overview
Table 84. Macleods Pharmaceuticals Citalopram Product
Table 85. Macleods Pharmaceuticals Revenue in Citalopram Business (2016-2021) & (US$ Million)
Table 86. Macleods Pharmaceuticals Recent Development
Table 87. Silarx Pharmacueticals Company Details
Table 88. Silarx Pharmacueticals Business Overview
Table 89. Silarx Pharmacueticals Citalopram Product
Table 90. Silarx Pharmacueticals Revenue in Citalopram Business (2016-2021) & (US$ Million)
Table 91. Silarx Pharmacueticals Recent Development
Table 92. Apotex Company Details
Table 93. Apotex Business Overview
Table 94. Apotex Citalopram Product
Table 95. Apotex Revenue in Citalopram Business (2016-2021) & (US$ Million)
Table 96. Apotex Recent Development
Table 97. Hikma Pharmaceuticals Company Details
Table 98. Hikma Pharmaceuticals Business Overview
Table 99. Hikma Pharmaceuticals Revenue in Citalopram Business (2016-2021) & (US$ Million)
Table 100. Hikma Pharmaceuticals Recent Development
Table 101. Jubilant Pharma Company Details
Table 102. Jubilant Pharma Business Overview
Table 103. Jubilant Pharma Citalopram Product
Table 104. Jubilant Pharma Revenue in Citalopram Business (2016-2021) & (US$ Million)
Table 105. Jubilant Pharma Recent Development
Table 106. Lupin Limited Company Details
Table 107. Lupin Limited Business Overview
Table 108. Lupin Limited Citalopram Product
Table 109. Lupin Limited Revenue in Citalopram Business (2016-2021) & (US$ Million)
Table 110. Lupin Limited Recent Development
Table 111. Prinston Pharmaceutical Company Details
Table 112. Prinston Pharmaceutical Business Overview
Table 113. Prinston Pharmaceutical Citalopram Product
Table 114. Prinston Pharmaceutical Revenue in Citalopram Business (2016-2021) & (US$ Million)
Table 115. Prinston Pharmaceutical Recent Development
Table 116. STI Pharma Company Details
Table 117. STI Pharma Business Overview
Table 118. STI Pharma Citalopram Product
Table 119. STI Pharma Revenue in Citalopram Business (2016-2021) & (US$ Million)
Table 120. STI Pharma Recent Development
Table 121. TEVA Pharmaceutical Company Details
Table 122. TEVA Pharmaceutical Business Overview
Table 123. TEVA Pharmaceutical Citalopram Product
Table 124. TEVA Pharmaceutical Revenue in Citalopram Business (2016-2021) & (US$ Million)
Table 125. TEVA Pharmaceutical Recent Development
Table 126. Hexal Company Details
Table 127. Hexal Business Overview
Table 128. Hexal Citalopram Product
Table 129. Hexal Revenue in Citalopram Business (2016-2021) & (US$ Million)
Table 130. Hexal Recent Development
Table 131. Shanghai Great Wall Pharmaceutical Company Details
Table 132. Shanghai Great Wall Pharmaceutical Business Overview
Table 133. Shanghai Great Wall Pharmaceutical Citalopram Product
Table 134. Shanghai Great Wall Pharmaceutical Revenue in Citalopram Business (2016-2021) & (US$ Million)
Table 135. Shanghai Great Wall Pharmaceutical Recent Development
Table 136. Wanquan Wante Pharmaceutical Company Details
Table 137. Wanquan Wante Pharmaceutical Business Overview
Table 138. Wanquan Wante Pharmaceutical Citalopram Product
Table 139. Wanquan Wante Pharmaceutical Revenue in Citalopram Business (2016-2021) & (US$ Million)
Table 140. Wanquan Wante Pharmaceutical Recent Development
Table 141. Northeast Pharmaceutical Group Company Details
Table 142. Northeast Pharmaceutical Group Business Overview
Table 143. Northeast Pharmaceutical Group Citalopram Product
Table 144. Northeast Pharmaceutical Group Revenue in Citalopram Business (2016-2021) & (US$ Million)
Table 145. Northeast Pharmaceutical Group Recent Development
Table 146. Sichuan Kelun Pharmaceutical Company Details
Table 147. Sichuan Kelun Pharmaceutical Business Overview
Table 148. Sichuan Kelun Pharmaceutical Citalopram Product
Table 149. Sichuan Kelun Pharmaceutical Revenue in Citalopram Business (2016-2021) & (US$ Million)
Table 150. Sichuan Kelun Pharmaceutical Recent Development
Table 151. Kunming Jida Pharmaceutical Company Details
Table 152. Kunming Jida Pharmaceutical Business Overview
Table 153. Kunming Jida Pharmaceutical Citalopram Product
Table 154. Kunming Jida Pharmaceutical Revenue in Citalopram Business (2016-2021) & (US$ Million)
Table 155. Kunming Jida Pharmaceutical Recent Development
Table 156. Jiangsu Enhua Pharmaceutical Company Details
Table 157. Jiangsu Enhua Pharmaceutical Business Overview
Table 158. Jiangsu Enhua Pharmaceutical Citalopram Product
Table 159. Jiangsu Enhua Pharmaceutical Revenue in Citalopram Business (2016-2021) & (US$ Million)
Table 160. Jiangsu Enhua Pharmaceutical Recent Development
Table 161. Southwest Pharmaceutical Company Details
Table 162. Southwest Pharmaceutical Business Overview
Table 163. Southwest Pharmaceutical Citalopram Product
Table 164. Southwest Pharmaceutical Revenue in Citalopram Business (2016-2021) & (US$ Million)
Table 165. Southwest Pharmaceutical Recent Development
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Citalopram Market Share by Type: 2020 VS 2027
Figure 2. Solution Features
Figure 3. Tablets Features
Figure 4. Other Features
Figure 5. Global Citalopram Market Share by Application: 2020 VS 2027
Figure 6. Depression Case Studies
Figure 7. Generalized Anxiety Case Studies
Figure 8. Obsessive Compulsive Disorder Case Studies
Figure 9. Somatoform Disorder Case Studies
Figure 10. Schizophrenia Case Studies
Figure 11. Other Case Studies
Figure 12. Citalopram Report Years Considered
Figure 13. Global Citalopram Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Citalopram Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Citalopram Market Share by Regions: 2020 VS 2027
Figure 16. Global Citalopram Market Share by Regions (2022-2027)
Figure 17. Global Citalopram Market Share by Players in 2020
Figure 18. Global Top Citalopram Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Citalopram as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Citalopram Revenue in 2020
Figure 20. Global Citalopram Revenue Market Share by Type (2016-2021)
Figure 21. Global Citalopram Revenue Market Share by Type (2022-2027)
Figure 22. North America Citalopram Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Citalopram Market Share by Type (2016-2027)
Figure 24. North America Citalopram Market Share by Application (2016-2027)
Figure 25. North America Citalopram Market Share by Country (2016-2027)
Figure 26. United States Citalopram Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Citalopram Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Citalopram Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Citalopram Market Share by Type (2016-2027)
Figure 30. Europe Citalopram Market Share by Application (2016-2027)
Figure 31. Europe Citalopram Market Share by Country (2016-2027)
Figure 32. Germany Citalopram Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Citalopram Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Citalopram Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Citalopram Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Citalopram Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Citalopram Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Citalopram Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Citalopram Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Citalopram Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Citalopram Market Share by Region (2016-2027)
Figure 42. China Citalopram Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Citalopram Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Citalopram Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Citalopram Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Citalopram Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Citalopram Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Citalopram Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Citalopram Market Share by Type (2016-2027)
Figure 50. Latin America Citalopram Market Share by Application (2016-2027)
Figure 51. Latin America Citalopram Market Share by Country (2016-2027)
Figure 52. Mexico Citalopram Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Citalopram Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Citalopram Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Citalopram Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Citalopram Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Citalopram Market Share by Country (2016-2027)
Figure 58. Turkey Citalopram Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Citalopram Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Citalopram Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. H.Lundbeck A/S Revenue Growth Rate in Citalopram Business (2016-2021)
Figure 62. Amneal Pharmaceuticals Revenue Growth Rate in Citalopram Business (2016-2021)
Figure 63. Aurobindo Pharma Revenue Growth Rate in Citalopram Business (2016-2021)
Figure 64. Hetero Drugs Revenue Growth Rate in Citalopram Business (2016-2021)
Figure 65. Macleods Pharmaceuticals Revenue Growth Rate in Citalopram Business (2016-2021)
Figure 66. Silarx Pharmacueticals Revenue Growth Rate in Citalopram Business (2016-2021)
Figure 67. Apotex Revenue Growth Rate in Citalopram Business (2016-2021)
Figure 68. Hikma Pharmaceuticals Revenue Growth Rate in Citalopram Business (2016-2021)
Figure 69. Jubilant Pharma Revenue Growth Rate in Citalopram Business (2016-2021)
Figure 70. Lupin Limited Revenue Growth Rate in Citalopram Business (2016-2021)
Figure 71. Prinston Pharmaceutical Revenue Growth Rate in Citalopram Business (2016-2021)
Figure 72. STI Pharma Revenue Growth Rate in Citalopram Business (2016-2021)
Figure 73. TEVA Pharmaceutical Revenue Growth Rate in Citalopram Business (2016-2021)
Figure 74. Hexal Revenue Growth Rate in Citalopram Business (2016-2021)
Figure 75. Shanghai Great Wall Pharmaceutical Revenue Growth Rate in Citalopram Business (2016-2021)
Figure 76. Wanquan Wante Pharmaceutical Revenue Growth Rate in Citalopram Business (2016-2021)
Figure 77. Northeast Pharmaceutical Group Revenue Growth Rate in Citalopram Business (2016-2021)
Figure 78. Sichuan Kelun Pharmaceutical Revenue Growth Rate in Citalopram Business (2016-2021)
Figure 79. Kunming Jida Pharmaceutical Revenue Growth Rate in Citalopram Business (2016-2021)
Figure 80. Jiangsu Enhua Pharmaceutical Revenue Growth Rate in Citalopram Business (2016-2021)
Figure 81. Southwest Pharmaceutical Revenue Growth Rate in Citalopram Business (2016-2021)
Figure 82. Bottom-up and Top-down Approaches for This Report
Figure 83. Data Triangulation
Figure 84. Key Executives Interviewed